This filing confirms the full exercise of the greenshoe option from the recent offering, which was already anticipated. The incremental dilution is modest relative to the $12.2B market cap. Monitor the pending senior housing acquisition for closing updates and the company's next earnings release for any guidance revision reflecting the use of proceeds.
Price Chart
Executive Summary
American Healthcare REIT (AHR) filed an 8-K on August 24, 2026, reporting the full exercise of the underwriters' option to purchase an additional 1,987,500 shares of common stock from its August 12, 2026 public offering. In connection with this, the company entered into additional forward sale agreements with Morgan Stanley, Citigroup, and KeyBanc, with the forward sellers borrowing and selling those shares on August 24, 2026. The net proceeds are intended to fund a pending acquisition of a senior housing portfolio, representing a routine capital markets update with no new financial data or material change in business operations.
Key Facts
- The underwriters' option to purchase up to 1,987,500 additional shares of common stock was exercised in full on August 20, 2026.
- The company entered into separate additional forward sale agreements with Morgan Stanley, Citigroup, and KeyBanc on August 20, 2026.
- The forward sellers borrowed and sold 1,987,500 shares on August 24, 2026 to hedge the forward purchasers' obligations.
- The company intends to deliver shares upon physical settlement of the forward agreements by August 10, 2028, in exchange for cash proceeds per share equal to the public offering price less underwriting discounts.
- Net proceeds from settlement are intended for the pending acquisition of a senior housing portfolio, potential future investments, and general corporate purposes.
- The initial public offering of 13,250,000 shares closed on August 12, 2026.
Financial Impact
The additional forward sale agreements cover 1,987,500 shares at an initial forward price of $53.4176 per share, implying potential gross proceeds of approximately $106.2 million upon physical settlement, before underwriting discounts and commissions.
Risk Factors
- Potential dilution of approximately 1.99 million shares upon settlement of the forward agreements.
- Execution risk on the pending senior housing portfolio acquisition.
- Forward sale agreements expose the company to stock price movements between now and settlement.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-363616 |
| Document: 0001193125-26-363616-index.html | 0001193125-26-363616 |
| Document: 0001193125-26-363616.txt | 0001193125-26-363616 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | 8-K | $53.40 $52.30 | ▼ −2.06% | ▼ −2.17% | $50.75 (−4.96%) |
Aug 24, 2026 5w ago | 8-K | $57.05 $56.54 | ▼ −0.89% | ▼ −0.35% | $50.75 (−11.04%) |
Aug 10, 2026 7w ago | 424B5 | $52.69 $54.42 | ▲ +3.28% | ▲ +3.69% | $50.75 (−3.68%) |
Aug 10, 2026 7w ago | 8-K | $52.69 $54.42 | ▲ +3.28% | ▲ +3.69% | $50.75 (−3.68%) |
Aug 3, 2026 8w ago | Institutional Cluster | $55.12 $55.47 | ▲ +0.64% | ▼ −1.39% | $50.75 (−7.93%) |
Jun 26, 2026 14w ago | 144 | $52.00 $53.83 | ▲ +3.52% | ▲ +2.13% | $50.75 (−2.40%) |
Jun 11, 2026 16w ago | Institutional Cluster | $46.81 $46.52 | ▼ −0.62% | ▼ −1.29% | $50.75 (+8.42%) |
May 21, 2026 19w ago | 424B5 | $50.19 $47.23 | ▲ +5.90% | ▲ +7.56% | $50.75 (−1.12%) |
May 20, 2026 19w ago | 424B5 | $50.13 $49.46 | ▼ −1.34% | ▼ −2.94% | $50.75 (+1.24%) |
Apr 7, 2026 25w ago | 8-K | $48.40 $49.48 | ▲ +2.23% | ▼ −1.29% | $50.75 (+4.86%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access